{"id":5072,"date":"2012-09-02T09:00:00","date_gmt":"2012-09-02T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/"},"modified":"2024-09-23T11:22:45","modified_gmt":"2024-09-23T11:22:45","slug":"rol-voor-tubercolosevaccin-bij-t1d","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/","title":{"rendered":"Rol voor tubercolosevaccin bij T1D?"},"content":{"rendered":"Er is hernieuwde aandacht voor het aloude BCG, een middel dat al lang geleden ontwikkeld is voor de bestrijding van tuberculose. BCG heeft een aantal interessante werkingen, zo stimuleert het de productie van TNF, tumor necrose factor. Dit is een potent cytotoxine dat door afweercellen wordt geproduceerd. In een nog zeer kleinschalig onderzoek kregen vrijwilligers met T1D enkele doses BCG toegediend. Het bleek dat na enige tijd dode autoreactieve T-cellen in het bloed opdoken, terwijl er daarvoor geen aanwijzig voor aanwezigheid van dergelijke cellen was. De onderzoekers vermoeden dat het lichaam autoreactieve T-cellen ergens in depot houdt en dat de verhoogde circulatie van TNF deze cellen doodt.\n\n<a href=\"http:\/\/asweetlife.org\/feature\/faustman-lab-research-how-excited-should-you-be\/\">Lees verder (Engelstalig)<\/a>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Er is hernieuwde aandacht voor het aloude BCG, een middel dat al lang geleden ontwikkeld is voor de bestrijding van tuberculose. BCG heeft een aantal interessante werkingen, zo stimuleert het de productie van TNF, tumor necrose factor. Dit is een potent cytotoxine dat door afweercellen wordt geproduceerd. In een nog zeer kleinschalig onderzoek kregen vrijwilligers [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,188],"tags":[],"class_list":["post-5072","post","type-post","status-publish","format-standard","hentry","category-archief","category-genezen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rol voor tubercolosevaccin bij T1D? - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rol voor tubercolosevaccin bij T1D? - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Er is hernieuwde aandacht voor het aloude BCG, een middel dat al lang geleden ontwikkeld is voor de bestrijding van tuberculose. BCG heeft een aantal interessante werkingen, zo stimuleert het de productie van TNF, tumor necrose factor. Dit is een potent cytotoxine dat door afweercellen wordt geproduceerd. In een nog zeer kleinschalig onderzoek kregen vrijwilligers [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2012-09-02T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:45+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Rol voor tubercolosevaccin bij T1D?\",\"datePublished\":\"2012-09-02T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\"},\"wordCount\":117,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\",\"Genezen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\",\"name\":\"Rol voor tubercolosevaccin bij T1D? - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2012-09-02T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rol voor tubercolosevaccin bij T1D?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rol voor tubercolosevaccin bij T1D? - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/","og_locale":"nl_NL","og_type":"article","og_title":"Rol voor tubercolosevaccin bij T1D? - Breakthrough T1D","og_description":"Er is hernieuwde aandacht voor het aloude BCG, een middel dat al lang geleden ontwikkeld is voor de bestrijding van tuberculose. BCG heeft een aantal interessante werkingen, zo stimuleert het de productie van TNF, tumor necrose factor. Dit is een potent cytotoxine dat door afweercellen wordt geproduceerd. In een nog zeer kleinschalig onderzoek kregen vrijwilligers [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/","og_site_name":"Breakthrough T1D","article_published_time":"2012-09-02T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:45+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Rol voor tubercolosevaccin bij T1D?","datePublished":"2012-09-02T09:00:00+00:00","dateModified":"2024-09-23T11:22:45+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/"},"wordCount":117,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief","Genezen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/","name":"Rol voor tubercolosevaccin bij T1D? - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2012-09-02T09:00:00+00:00","dateModified":"2024-09-23T11:22:45+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/rol-voor-tubercolosevaccin-bij-t1d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Rol voor tubercolosevaccin bij T1D?"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5072"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5072\/revisions"}],"predecessor-version":[{"id":7284,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5072\/revisions\/7284"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}